Scientists test Patient's own supercharged immune cells to fight tough cancers
NCT ID NCT06190275
Summary
This early-stage study is testing the safety of a new, personalized treatment for advanced head and neck cancer. Doctors take a patient's own immune cells from a tumor, grow large numbers of them in a lab, and infuse them back into the patient along with a standard immunotherapy drug. The goal is to see if this combined approach is safe and can help control the cancer in people whose disease has come back or spread.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HNSCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Ninth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, 200000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.